• OPEN AN ACCOUNT
Indian Indices
Nifty
24,855.05 33.95
(0.14%)
Sensex
81,481.86 143.91
( 0.18%)
Bank Nifty
56,150.70 -71.30
( -0.13%)
Nifty IT
35,481.70 108.45
( 0.31%)
Global Indices
Nasdaq
44,493.70 160.30
(-0.36%)
Dow Jones
6,385.66 -6.20
(-0.10%)
Hang Seng
40,625.11 -49.44
(-0.12%)
Nikkei 225
9,136.94 0.62
(0.01%)
Forex
USD-INR
86.63 0.12
(0.14%)
EUR-INR
101.04 -0.54
(-0.53%)
GBP-INR
116.12 -0.10
(-0.09%)
JPY-INR
0.58 0.00
(-0.22%)

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532531
INE939A01011
346.3871872
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
STAR
141.36
8716.77
EPS(TTM)
Face Value()
Div & Yield %
6.69
10
0.42
 

mahindra & mahindra ltd
Maruti Suzuki sales dip 6.27% YoY to 167,993 units in June’25
Jul 02,2025

The sales of domestic passenger vehicles stood at 1,18,906 units (down 13.30% YoY), while sales of light commercial vehicles came in at 2,433 units (down 11.78% YoY) during the period under review.

While the company's total domestic sales (PV+LCV+OEM) declined 12.17% YoY to 1,30,151 units, total export sales increased by 21.94% YoY to 37,842 units sold in June 2025.

Meanwhile, the car manufacturer’s total production fell 4.16% to 1,27,545 units in June 2025 as against 1,33,095 units recorded in June 2024.

In June’25, the production of passenger vehicles was at 1,25,392 units, down 4.22% from 1,30,930 units produced in June 2024. Additionally, the production of light commercial vehicles reached 2,153 units in June 2025, registering a YoY decline of 0.55%.

Maruti Suzuki India is engaged in the manufacture, purchase, and sale of motor vehicles, components, and spare parts (automobiles).

The company has reported 4.3% fall in standalone net profit to Rs 3,711.1 crore despite a 5.9% increase in net sales to Rs 38,848.8 crore in Q4 FY25 as compared with Q4 FY24.

Shares of Maruti Suzuki India rose 0.02% to Rs 12,445 on the BSE.